	US 11,752,128 B2
	Benzimidazoles and indoles as taro inhibitors
John P. Caldwell, Ringwood, NJ (US); Ginny Dai Ho, Murray Hill, NJ (US); Sookhee N. Ha, Warren, NJ (US); Sandra J. Koseoglu, Fanwood, NJ (US); Marc A. Labroli, West Point, PA (US); Sang Ho Lee, Berkeley Heights, NJ (US); Christina Madsen-Duggan, Scotch Plains, NJ (US); Mihir Mandal, Westfield, NJ (US); Jianping Pan, Monmouth Junction, NJ (US); Weidong Pan, Hillsborough, NJ (US); Terry Roemer, Cranford, NJ (US); Jing Su, Scotch Plains, NJ (US); Christopher Michael Tan, Scotch Plains, NJ (US); Zheng Tan, Westfield, NJ (US); Hao Wang, Scotch Plains, NJ (US); Christine Yang, New Brunswick, NJ (US); and Shu-Wei Yang, Edison, NJ (US)
Assigned to MERCK SHARP & DOHME CORPORATION, Rahway, NJ (US)
Filed by MERCK SHARP & DOHME CORP., Rahway, NJ (US)
Filed on Jul. 26, 2021, as Appl. No. 17/385,194.
Application 17/385,194 is a continuation of application No. 16/061,481, granted, now 11,141,403, previously published as PCT/US2016/066277, filed on Dec. 13, 2016.
Claims priority of provisional application 62/268,122, filed on Dec. 16, 2015.
Prior Publication US 2021/0346344 A1, Nov. 11, 2021
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/397 (2006.01); A61P 31/04 (2006.01); A61K 31/407 (2006.01); C07D 235/08 (2006.01); C07D 401/04 (2006.01); C07D 401/14 (2006.01); C07D 403/04 (2006.01); C07D 403/06 (2006.01); C07D 471/04 (2006.01)

CPC A61K 31/397 (2013.01) [A61K 31/407 (2013.01); A61P 31/04 (2018.01); C07D 235/08 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 403/04 (2013.01); C07D 403/06 (2013.01); C07D 471/04 (2013.01)]

3 Claims

1. A TarO inhibitor compound is selected from:

or a pharmaceutically acceptable salt thereof.